DatasetName,BNIP2_S(111) BNIP2_S(112) BNIP2_S(114) BNIP2_S(2) BNIP2_S(3) BNIP2_T(116) BNIP2_T(119) BNIP2_T(237),BNIP2_S(235) BNIP2_T(111)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.5549974609777738,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,0.5503476041149347,
RCJD2014_15min_1,0.5492518548804816,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5483697664524272,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,0.5600866731322137,
GF2025_P2_Sph,0.5627099000606008,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5764458864112109,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.5659496422832593,
RB2022_5_PreEndurance,0.5666933124322817,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.6457978205814771
EP2017_Untreated R#4 normalized log2 ratio,0.5747688003065159,
WZ2023_Pu_010_30min,0.5735408145553698,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.5669544733049502,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.5747832769483847,
KBE2022_Log2_Ex_14_U,0.5668939508750492,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.5744163982932864,
RB2022_5_PreSprint,0.581763702397972,
PG2020_Intensity 8h_C,0.5647887313863744,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5813827345587991,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.5719599169325565,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5688824529845525,
GF2025_P6_Sph,0.5753879606756279,
RB2022_2_PreSprint,0.5817615233620751,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.577718661012795,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5733913341952253,
WZ2023_Pu_005_10min,0.5805120025504013,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5834504069633972,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5809696667662386,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5273468924254079,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5585483297169149,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5711229802720807,
EJN2021_3_Rest_Basal,,0.6816807169430024
CR2017_Ratio Replicate 1.3,0.536687275862613,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5658774999647928,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5757419882066366,
CK2022_11 40-1,0.58301906442462,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5212412094021319,0.6919060701834125
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5777057828182717,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5554890914839997,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.6303828864856341
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.5565053550515278,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.5637258874246582,
RCJD2014_20min_mean,0.5385631784809396,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.5558634859337264,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5402588387816264,
CK2022_1 200-1,0.5693796951061723,
PG2020_Intensity Mock_10h_D,0.5756715666208334,
SR2019_MCF10A_Biol_repl_2,0.5628442036108547,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5479408650404152,
RCJD2014_5min_1,0.5674457853594934,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5345020219989423,
PG2020_Intensity 2h_C,0.5383359822414611,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.5638563004233887,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5631991837037131,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,0.5779838212664641,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5687412666200894,0.7176764830009296
ZQ2022_N2,0.5412762566735447,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,0.677391173726032
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5376031269402423,
SR2019_Hs578T_Biol_repl_3,0.5549496606555719,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.564622023759689,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5664463215330524,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5739679299077866,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5779025759042435,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5474815753250722,
KS2014_Intensity N3,0.5292534259942506,0.7128728411844385
RB2022_4_RecoveryEndurance,0.5758501282275884,
RB2022_5_RecoveryEndurance,0.5666139251273642,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.6010517011782208
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5698395702566201,
KS2014_Intensity E15_2,,0.6782976454437224
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5626694545765275,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.537480031191599,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5608650091387757,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.571479349679257,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5930188923115933,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5788001899391848,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5477725089130823,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5772801371157795,0.6986127602075005
SR2019_HCC1954_Biol_repl_2,0.5563710967183912,
CK2022_14 40-1,0.5806807578110263,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5514980127786215,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5951646357121001
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,0.6792188977561808
RN2012_H05,0.5506373707051762,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5478343777717029,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5705690380234927,
EJN2021_1_Rest_Ins,,0.6978176319344339
HH2022_Reporter intensity 3,0.5523032123629761,0.6614031268818472
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5720315959456314,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5844028635537479,
CK2022_12 200-1,0.5874940759513603,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5744826075641054,0.6414862921195146
WZ2023_Su_010_20min,0.5774346655996162,
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5785168496750237,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.567141595270373,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.5492791837968707,0.7182591265218237
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5625781416861562,
CK2022_14 200-1,0.5778842018329252,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5763741524287215,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.6831801248622772
SR2019_LM2_Biol_repl_4,0.5595623065673062,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5588376345093579,
GF2025_P1_Adh,0.5548327121891387,
GF2025_P1_Sph,0.57169000070336,
EJN2021_5_Ex_Basal,,0.680998871582236
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5781731054230027,
CF2017_EOC 1,0.5518637247066226,
CK2022_3 200-1,0.5694495127875129,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5663512761017687,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.5617180819426162,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5780845666056966,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5687197754087979,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5532198194948189,
AR2021_ALG 1 μM,,0.5568396750341882
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.5651662466875187,
EJN2021_1_Rest_Basal,,0.6919493311748445
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5457541617579373,
CR2017_Ratio Replicate 3.2,0.5423442364516579,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5645463753411031,
CK2022_9 16-1,0.5660629263378543,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5794927635749524,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5253908447370804,
CK2022_16 16-1,0.5569317833933125,
FS2019_db/db3,,
CK2022_15 40-1,0.5791019789366223,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.577651898980142,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5856440943510571,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5670803382219515,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.595890227199854,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5648227209718726,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5565688626156895,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5680910694697211,
RN2012_L13,0.5594748343589633,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5798038912245388,
SR2019_SKBR3_Biol_repl_3,0.5557880677680421,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5833437534598425,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,0.581158865385019,0.6335984261338824
RB2022_2_RecoveryStrength,0.5627477424955111,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,0.5475563821218197,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,0.5671516657642575,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.5897832371734621
RB2022_4_PostStrength,0.5716143031819151,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5352951805739444,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5643139009933235,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5604795382242416,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5496557922500908,0.6757731054681723
HH2022_Reporter intensity 1,0.5519472466924696,0.6583563415049618
HH2022_Reporter intensity 2,0.5507632997665957,0.6649795034678165
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5000226970833015,
SR2019_LM2_Biol_repl_3,0.5619675497601948,
RB2022_4_RecoveryStrength,0.557032115320364,
CR2017_Ratio Replicate 2,0.5676353011564853,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.568783017696575,0.6078233681447764
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5746410624699838,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.5548943001304375,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.5643534531159063,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5602397565254376,
PG2020_Intensity Mock_10h_C,0.5750459003266482,
CF2017_OSE 29,0.5708541087016855,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5374431617188433,
RN2012_L12,0.5869086184849425,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5797162635382327,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.687939472139183
TM2022_S2.12h.B,,
RN2012_L15,0.5092843415524715,
KS2014_Intensity pY_PV3,,0.6006835728413495
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5563751889312026,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5767786589597962,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5451093607554518,0.7378732458400209
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5687352081163457,
CK2022_5 200-1,0.5684090807351205,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.6291102579248723
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.5638874094144455,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5719914571453322,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,0.6803320831600534
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5456514465873975,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.6907460354873751
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5646098916306723,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5614618221361215,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5659640481322473,
WZ2023_Pe_025_20min,0.5797450086130798,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,
RN2012_H06,0.538829495352674,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.573381059011925,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.54381945066439,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5521634101901877,
WZ2023_Su_025_10min,0.5797162157348552,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.5569995281501796,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.577280886029579,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5832129427098504,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5585554126298261,0.72820688981729
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5612904291235394,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5632555518522987,
RN2012_L10,0.5547988576797176,
PG2020_Intensity 4h_C,0.5565665198083141,
EP2017_Mitotic R#3 normalized log2 ratio,0.5402074265049139,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5781094580864929,
RB2022_8_PostStrength,0.5778507577597086,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5735599424579632,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5819938485199341,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.6178609225551128
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5784605618244241,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5477206222298295,
GF2025_P9_Sph,0.5629298248187375,
CK2022_6 200-1,0.5680971714899615,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.5513378768121466,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5537569889962328,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5453591841351216,
EP2017_Untreated R#3 normalized log2 ratio,0.5694885155238855,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5679070323812359,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5219878612107005,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.586022818571752,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.5943728718347778
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.6409365487647007
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5681872421019303,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.6752971268363414
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.5741742554460729,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5604904993627637,
PG2020_Intensity CT_C,0.5613671984004382,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.575657612180088
KBE2022_Log2_Ex_39_U,0.559780177103946,
EP2017_Untreated R#3 log2 ratio,0.5655799564391139,
RB2022_2_PostStrength,0.5770039495212775,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5228018431971944,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.6180879190911993
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6031339075784004,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5438091842790493,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5609499107004667,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.6219135503971239
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5670296383054875,
CK2022_2 16-1,0.5438022079210091,
RAM2015_Log2 B,,0.5893658633609905
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.6828055653664772
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5681008681237476,
WZ2023_Su_025_30min,0.5776261022998946,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.533006462271033,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5549478736583886,0.6419476272544047
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5511726797034794,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,0.5522941294658981,
RB2022_8_PreStrength,0.5667818856842233,
KS2014_Intensity C5,0.5632015646252595,0.7573858499144674
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5468118480911377,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,0.5626380233743787,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5646975366390674,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.5698041368245693,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.5669217742871732,
KS2014_Intensity E15_3,,0.6862917434946081
GF2025_P3_Sph,0.5567138562042969,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5477096042070262,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.5742624690727371,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5641069172131229,
ZQ2022_N1,0.5425829036120704,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.45447512706268617,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5839187862632383,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.6592678006479546
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5794370238331786,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.563529133894864,
SR2019_BT549_Biol_repl_2,0.5634273841321789,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5529010599293368,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5748377029937036,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.6385646849455766
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.6455869535719596
CK2022_13 40-1,0.5799686361189907,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5755662530736914,
PG2020_Intensity 10h_D,0.5456684787498928,
RB2022_8_PreEndurance,0.5796629488410743,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.6913274621157504
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.6782905589455359
EP2017_Pervanadate R#3 log2 ratio,0.5780037556718949,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5717000206975332,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.6414376657539481
RN2012_H04,0.5636716955467744,
CK2022_6 40-1,0.5798688450531388,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5727131953172133,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.6835628747024745
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.579451915054749,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.6819146642989709
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.544531326613871,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5740873042134861,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5735147112528238,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,0.583984838309895,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,0.5800360758998391,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.5594902835465817,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5614359824459811,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5676351207865318,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5616458849343977,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5786408590595417,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5881003919425916,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5775160043903981,
SR2019_MCF10A_Biol_repl_4,0.5625569985062102,
KS2014_Intensity pY_C5,,0.615165653233615
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5711564770617631,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5872231580611815,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,0.556692108817238,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5455401946313869,
KBE2022_Log2_Ex_36_T,0.5809411256039198,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5774278249163654,
KS2014_Intensity C2,0.5642366100036255,0.7542802018998056
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5684999565264368,
CK2022_9 200-1,0.5849398065737496,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5842834655972253,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5229136004202267,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5386337355818316,0.6610925873915635
ZQ2022_C3,0.5654325556894444,
EJN2021_3_Rest_Ins,,0.6904005741357961
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5656179417652082,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5591047953335142,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5778769908484558,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5526556579758697,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5428575858678355,0.672218574890457
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5804601920393305,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.6399163403300376
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5497485099344666,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.5483180932243413,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5604614011913663,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5624786480864369,0.6063121822691662
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.5596329264118721,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5771401889688645,
KBE2022_Log2_Ex_29_U,0.5659041370212583,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5781478420006114,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5734610143854035,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.568933707928127,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5776739345798817,
RN2012_H01,0.577073591412971,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.6859370283234398
KS2014_Intensity pY_E5_3,,0.610125458927109
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5859564005305509,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5693191209923812,
WZ2023_Pe_010_20min,0.5759014716494696,
KS2014_Intensity pY_C6,,0.6254575811993464
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5686485302777433,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5395608700301873,
KS2014_Intensity C1,0.5611048891275309,0.7629090016538032
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5924405942470714,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5798654038847846,
PG2020_Intensity 6h_C,0.5472948299564538,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,0.556766266853914,
CK2022_3 16-1,0.5450485045236498,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5539890845540133,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5561904071745176,
CK2022_10 16-1,0.5670001212136176,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5621768565298368,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.552464376215275,
EJN2021_2_Ex_Basal,,0.6810603983513341
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.674685541977827
CF2017_FTE 16,0.555153814512476,
AR2021_L41 10 μM,,0.5804363017539236
CF2017_EOC 2,0.5618027880183997,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5491092981664414,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.551862921810882,0.6604991630069332
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,0.5843815225018075
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5652578423959284,0.7574475754118324
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5583601925242048,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.570263128029904,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.5607247293292716,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.610241657718509
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5775919884176641,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.5822650143326302,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5470708308834396,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,0.5534854969602722,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.569370979353546,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5761757103669631,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5644384070693951,0.751968601056155
ZQ2022_N3,0.5522559406270499,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5847876972935937,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5800311681650985,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.5801748075962504,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,0.562833619441496,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.5515733493982041,
CR2017_Ratio Replicate 2.2,0.5670037718818042,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5665911213527102,
ZQ2022_C1,0.5729819187935488,
CR2017_Ratio Replicate 2.1,0.5393491400165914,
PG2020_Intensity CT_B,0.5653145797153187,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,0.6064871371245635
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5418239400504984,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5613502434825871,
RB2022_2_PreEndurance,0.571400817632421,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5731564228334138,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5598246089494942,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5949933694972547,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5522596521000895,
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.5582996162375478,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.6873259475800773
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.5710410258084989,0.6197262033158719
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5717511151163517,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5729863203532769,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,0.5378733105238903,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,0.5650900189384601,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5631660890530595,
SR2019_HCC1419_Biol_repl_3,0.548747108591961,
KBE2022_Log2_Ex_14_T,0.569191527202796,
EP2017_Untreated R#2 normalized log2 ratio,0.5016230284081215,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5830011523040759,
AS2011_Ratio H/L Normalized RNAi_2_1,,
